These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25161986)

  • 1. Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.
    Baseri M; Heidari R; Mahaki B; Hajizadeh Y; Momenizadeh A; Sadeghi M
    Adv Biomed Res; 2014; 3():139. PubMed ID: 25161986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of myeloperoxidase, homocysteine and high-sensitivity C-reactive protein with the severity of coronary artery disease and their diagnostic and prognostic value.
    Cheng M; Cheng M; Wei Q
    Exp Ther Med; 2020 Aug; 20(2):1532-1540. PubMed ID: 32765675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma myeloperoxidase is related to the severity of coronary artery disease.
    Düzgünçinar O; Yavuz B; Hazirolan T; Deniz A; Tokgözoğlu SL; Akata D; Demirpençe E
    Acta Cardiol; 2008 Apr; 63(2):147-52. PubMed ID: 18468192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
    Kruszelnicka O; Surdacki A; Golay A
    Cardiovasc Diabetol; 2013 Oct; 12():145. PubMed ID: 24103320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
    Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
    J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
    Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
    J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
    de Azevedo Lucio E; Gonçalves SC; Ribeiro JP; Nunes GL; de Oliveira JR; Araujo GN; Wainstein MV
    Inflamm Res; 2011 Feb; 60(2):137-42. PubMed ID: 20848159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease.
    Seyedian SM; Ahmadi F; Dabagh R; Davoodzadeh H
    ARYA Atheroscler; 2016 Sep; 12(5):231-237. PubMed ID: 28458698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
    Samsamshariat SZ; Basati G; Movahedian A; Pourfarzam M; Sarrafzadegan N
    Biomark Med; 2011 Jun; 5(3):377-85. PubMed ID: 21657847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease].
    Ma Y; Rao J; Long J; Lin L; Liu J; Guo Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):235-240. PubMed ID: 30890514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
    Kubala L; Lu G; Baldus S; Berglund L; Eiserich JP
    Clin Chim Acta; 2008 Aug; 394(1-2):59-62. PubMed ID: 18440308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound.
    Kataoka Y; Shao M; Wolski K; Uno K; Puri R; Murat Tuzcu E; Hazen SL; Nissen SE; Nicholls SJ
    Atherosclerosis; 2014 Feb; 232(2):377-83. PubMed ID: 24468151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
    Wainstein RV; Wainstein MV; Ribeiro JP; Dornelles LV; Tozzati P; Ashton-Prolla P; Ewald IP; Vietta G; Polanczyk CA
    Clin Biochem; 2010 Jan; 43(1-2):57-62. PubMed ID: 19651119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.